Melpomeni Fani

10PUBLICATIONS
15CO-AUTHORS
Biologically active moleculesPredictive and prognostic markersCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 06, 2026
Development of dual SST2/SST5 targeting radioligands through rational structural design.

|Aug 21, 2025
Enhanced contrast in FAP-targeting PET imaging with 61Cu-labeled FAP inhibitors: development and preclinical evaluation of novel [61Cu]Cu-Kalios PET radioligands.

Jacopo Millul, Tais Basaco Bernabeu, Raghuvir H Gaonkar

|Jul 01, 2025
Pyridyl-Ala in the third position of radiolabeled somatostatin antagonists: the effect of regioisomeric substitution.

Rosalba Mansi, Natalie Bertarelli, Luigi Del Pozzo

|Jan 09, 2025
Improving Affinity while Reducing Kidney Uptake of CXCR4-Targeting Radioligands Derived from the Endogenous Antagonist EPI-X4.

Raghuvir H Gaonkar, Thibaud Bailly, Jacopo Millul

|Jun 01, 2023
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides.

Jacopo Millul, Lennart Koepke, Gaonkar Raghuvir Haridas

|Mar 29, 2023
Development of the 99mTc-Labelled SST2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study.

Doroteja Novak, Barbara Janota, Anton Amadeus Hörmann

Pageof 2

Frequent Collaborators

6 joint publications

Rosalba Mansi

1 joint publications

Guillaume P Nicolas

1 joint publications

Barbara Janota

1 joint publications

Agnieszka Sawicka